Molecular basis for the DNA damage induction and anticancer activity of asymmetrically substituted anthrapyridazone PDZ-7
Abstrakt
nthrapyridazones, imino analogues of anthraquinone, constitute a family of compounds with remarkable anti-cancer activity. To date, over 20 derivatives were studied, of which most displayed nanomolar cytotoxicity towards broad spectrum of cancer cells, including breast, prostate and leukemic ones. BS-154, the most potent derivative, had IC50 values close to 1 nM, however, it was toxic in animal studies. Here, we characterize another anthrapyridazone, PDZ-7, which retains high cytotoxicity while being well tolerated in mice. PDZ-7 is also active in vivo against anthracycline-resistant tumor in a mouse xenograft model and induces DNA damage in proliferating cells, preferentially targeting cells in S and G2 phases of the cell cycle. Activation of Mre11-Rad50-Nbs1 (MRN) complex and phosphorylation of H2AX suggest double-stranded DNA breaks as a major consequence of PDZ-7 treatment. Consistent with this, PDZ-7 treatment blocked DNA synthesis and resulted in cell cycle arrest in late S and G2 phases. Analysis of topoisomerase IIα activity and isolation of the stabilized covalent topoisomerase IIα - DNA complex in the presence of PDZ-7 suggests that this compound is a topoisomerase IIα poison. Moreover, PDZ-7 interfered with actin polymerization, thereby implying its action as a dual inhibitor of processes critical for dividing cells. Using nuclear magnetic resonance (NMR) spectroscopy we show that PDZ-7 interacts with DNA double helix and quadruplex DNA structure. Taken together, our results suggest that PDZ-7 is a unique compound targeting actin cytoskeleton and DNA.
Cytowania
-
5
CrossRef
-
0
Web of Science
-
5
Scopus
Autorzy (16)
Cytuj jako
Pełna treść
- Wersja publikacji
- Accepted albo Published Version
- Licencja
- otwiera się w nowej karcie
Słowa kluczowe
Informacje szczegółowe
- Kategoria:
- Publikacja w czasopiśmie
- Typ:
- artykuł w czasopiśmie wyróżnionym w JCR
- Opublikowano w:
-
Oncotarget
nr 10,
strony 105137 - 105154,
ISSN: 1949-2553 - Język:
- angielski
- Rok wydania:
- 2017
- Opis bibliograficzny:
- Misiak M., Heldt M., Szeligowska M., Mazzini S., Scaglioni L., Grabe G., Serocki M., Lica J., Świtalska M., Wietrzyk J., Beretta G., Perego P., Ziętkowski D., Bagiński M., Borowski E., Składanowski A.: Molecular basis for the DNA damage induction and anticancer activity of asymmetrically substituted anthrapyridazone PDZ-7// Oncotarget. -Vol. 10, nr. 8 (2017), s.105137-105154
- DOI:
- Cyfrowy identyfikator dokumentu elektronicznego (otwiera się w nowej karcie) 10.18632/oncotarget.21806
- Weryfikacja:
- Politechnika Gdańska
wyświetlono 217 razy
Publikacje, które mogą cię zainteresować
H2AX phosphorylation, its role in DNA damage response and cancer therapy
- M. Podhorecka,
- A. Składanowski,
- P. Bożko
PARP inhibition potentiates the cytotoxic activity of C-1305, a selective inhibitor of topoisomerase II, in human BRCA1-positive breast cancer cells
- J. Węsierska-Gądek,
- N. Zulehner,
- F. Ferk
- + 3 autorów
Quinoline-based thiazolyl-hydrazones target cancer cells through autophagy inhibition
- V. Ćurčić,
- M. Olszewski,
- N. Maciejewska
- + 11 autorów